This Month in Psychopharmacology

Liraglutide for Weight Loss in Stable Bipolar Disorder

An all-too-common comorbidity for those suffering with bipolar diso...

Read More

ADHD Medications and Long-Term Risk of Cardiovascular Diseases: New Data

This recently published case-control study explores the potential c...

Read More

Sexual Dysfunction in Schizophrenia

Schizophrenia has high prevalence rates of sexual dysfunction; howe...

Read More

Antipsychotic Polypharmacy Increases Risk of Hypertension, Study Suggests

In some cases, treating schizophrenia is especially difficult and m...

Read More

Risk of Akathisia Differs Among Antipsychotics and Dosage

Akathisia is a movement disorder that consists of increased motor a...

Read More

Role of the Gut-Brain Axis and Psychiatric Diseases

Numerous studies have found a profound association between gastroin...

Read More

Tardive Dyskinesia Awareness Week

Every year, we recognize the first full week of May as Tardive Dysk...

Read More

Potential Add-On Therapy To An Antipsychotic For Treatment-Resistant Schizophrenia

Interim results from an exploratory clinical trial demonstrate sust...

Read More

Risk of Cardiovascular Diseases Associated With Medications Used in ADHD

In a recent cohort study, the relationship benzodiazepines versus a...

Read More

FDA Resource for Dietary Supplements

The U.S. Food and Drug Administration has released a resource for c...

Read More

Screening for Tardive Dyskinesia

The American Academy of Neurology (AAN) has released updated recomm...

Read More

2021 NEI Congress Taking a Bite Out of Nutrition and Mental Health

During the 2021 NEI Congress, Dr. Andrew Cutler presented a fascina...

Read More